BridgeMD
New treatment option for Infraclavicular Brachial Plexus Block
Official title Impact of Bupivacaine Dilution With Dextrose or Saline on Infraclavicular Block Outcomes
ClinicalTrials.gov ID: NCT07386327
What this study is testing
- What it's testing
- D5W) has long been used as an intravenous fluid for hydration and energy supplementation and has recently gained increasing clinical interest in perineural injection therapies and ultrasound-guided hydrodissection. D5W has been shown to improve pain and functional outcomes in entrapment neuropathies by mechanically releasing perineural adhesions and potentially modulating neurogenic inflammation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patients who agree to participate in the study and provide written informed consent
- Patients scheduled for elective upper extremity surgery for whom infraclavicular block is considered appropriate for anesthetic management
- Age between 18 and 65 years
- American Society of Anesthesiologists (ASA) physical status I-III
- Patients with a normal neurological examination in the extremity scheduled for peripheral nerve block
You likely can't join if
- Patients who decline to participate in the study or refuse to provide informed consent
- History of allergy or hypersensitivity to study medications
- Body mass index (BMI) ≥ 30 kg/m²
- Body weight less than 40 kg
- Age below 18 years or above 65 years
- History of significant cardiac disease (e.g., arrhythmia, conduction disorders)
See the full eligibility criteria
- Patients who agree to participate in the study and provide written informed consent
- Patients scheduled for elective upper extremity surgery for whom infraclavicular block is considered appropriate for anesthetic management
- Age between 18 and 65 years
- American Society of Anesthesiologists (ASA) physical status I-III
- Patients with a normal neurological examination in the extremity scheduled for peripheral nerve block
- Patients who decline to participate in the study or refuse to provide informed consent
- History of allergy or hypersensitivity to study medications
- Body mass index (BMI) ≥ 30 kg/m²
- Body weight less than 40 kg
- Age below 18 years or above 65 years
- History of significant cardiac disease (e.g., arrhythmia, conduction disorders)
- Presence of coagulopathy (international normalized ratio [INR] \> 1.5 and/or platelet count \< 100,000/mm³)
- Hepatic failure or significant liver dysfunction
- Pregnant patients
- Infection at the planned peripheral block site
- Presence of neurological deficit in the extremity planned for peripheral nerve block
- Patients with uncontrolled diabetes mellitus and/or established diabetic neuropathy
- American Society of Anesthesiologists (ASA) physical status IV
The study team makes the final eligibility decision.
Where it's taking place
- Sakarya, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sakarya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.